rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
1990-12-7
|
pubmed:abstractText |
Anti-Tac(Fv)-PE40 is a recombinant single-chain immunotoxin containing the heavy and light variable regions of the anti-Tac monoclonal antibody fused to a mutant form of Pseudomonas exotoxin (PE). Anti-Tac binds to the p55 subunit of the human interleukin 2 (IL-2) receptor, and anti-Tac(Fv)-PE40 kills human or monkey cell lines that contain either the intact IL-2 receptor or its p55 subunit alone. To assess the usefulness of anti-Tac(Fv)-PE40 in treatment of IL-2 receptor-positive leukemia, we tested peripheral blood mononuclear cells from six patients with adult T-cell leukemia. In each of the six patients, anti-Tac(Fv)-PE40 was extremely cytotoxic to the malignant cells. Metabolic activity and sensitivity of the fresh cells improved when a small amount of IL-2 (10 units per ml) was present during incubation. The toxin concentration necessary to inhibit protein synthesis by 50% after 16-hr incubation of cells with immunotoxin varied from 1.6 to 16 ng/ml (2.5-25 x 10(-11) M). In every case, binding was by means of the Tac antigen because anti-Tac(Fv)-PE40 cytotoxicity was prevented by adding excess anti-Tac antibody. Moreover, anti-Tac alone or an inactive mutant of anti-Tac(Fv)-PE40 without ADP-ribosylation activity had very little cytotoxic activity. Peripheral blood mononuclear cells from normal controls, from a patient with Tac-negative leukemia, and from adult T-cell leukemia patients without significant peripheral blood involvement were not sensitive to anti-Tac(Fv)-PE40. These results indicate that anti-Tac(Fv)-PE40 is a potent cytotoxin against adult T-cell leukemia cells in vitro and warrants clinical testing.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2118522,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2467293,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2498664,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2510169,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2786749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2885323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-2986744,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3098436,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3132465,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3143716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-3283735,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6261256,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6602943,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6970774,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236041-6979048
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ADP Ribose Transferases,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Toxins,
http://linkedlifedata.com/resource/pubmed/chemical/Exotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Variable Region,
http://linkedlifedata.com/resource/pubmed/chemical/Immunotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Virulence Factors,
http://linkedlifedata.com/resource/pubmed/chemical/toxA protein, Pseudomonas aeruginosa
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0027-8424
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8291-5
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2236041-ADP Ribose Transferases,
pubmed-meshheading:2236041-Antibodies, Monoclonal,
pubmed-meshheading:2236041-Antigens, CD,
pubmed-meshheading:2236041-Bacterial Toxins,
pubmed-meshheading:2236041-Cell Line,
pubmed-meshheading:2236041-Cell Survival,
pubmed-meshheading:2236041-Exotoxins,
pubmed-meshheading:2236041-Female,
pubmed-meshheading:2236041-Humans,
pubmed-meshheading:2236041-Immunoglobulin Variable Region,
pubmed-meshheading:2236041-Immunotoxins,
pubmed-meshheading:2236041-Leukemia, T-Cell,
pubmed-meshheading:2236041-Leukemia-Lymphoma, Adult T-Cell,
pubmed-meshheading:2236041-Leukocytes, Mononuclear,
pubmed-meshheading:2236041-Male,
pubmed-meshheading:2236041-Pseudomonas,
pubmed-meshheading:2236041-Tumor Cells, Cultured,
pubmed-meshheading:2236041-Virulence Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
|
pubmed:affiliation |
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
|
pubmed:publicationType |
Journal Article
|